Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 888 (ZNF888) is a member of the **C2H2-type zinc finger protein family**, the largest group of transcription factors in humans[2][3][1][4]. Like other zinc finger proteins, ZNF888 likely contains multiple zinc finger motifs that confer sequence-specific DNA-binding and gene regulatory activity. Zinc finger proteins are highly diverse and participate in fundamental biological processes such as transcriptional regulation, cell differentiation, and apoptosis[1][2][3][4]. Most reported functions, disease associations, and drug interactions involve other zinc finger proteins rather than ZNF888 specifically. To date, ZNF888 itself is not established as a therapeutic target, biomarker, or directly implicated in human disease. Essential context: - Zinc finger proteins function as transcription factors through their ability to bind DNA and regulate gene expression[2][1][3][4]. - The C2H2 zinc finger domain is the most common, featuring a conserved structure that interacts specifically with DNA[2][4]. - Although the broader zinc finger protein family is implicated in cancer, neurodegeneration, and other conditions, there is no evidence of clinical targeting or disease association for ZNF888 itself[3][1]. - No current drug or small molecule interaction is reported for ZNF888, nor is it used as a therapeutic biomarker or a direct clinical target. If more information on ZNF888 becomes available or if additional research emerges, its role as a target may be re-evaluated. At present, it should be considered a **generic transcription factor** without strong therapeutic or biomarker significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 888 (ZNF888).